Trends in migraine incidence among women of childbearing age from 1990 to 2019 and the prediction for 2030: an analysis of national data in China

被引:4
|
作者
Fan, Zhuanzhuan [1 ]
Kang, Jian [2 ]
Li, Wenting [1 ]
Wang, Zhiyong [1 ]
Qiao, Huifen [3 ]
Xu, Fei [1 ,4 ]
机构
[1] Nanjing Med Univ, Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Peoples R China
[2] First Affiliated Hosp Nanjing Med Univ, Nanjing, Peoples R China
[3] Nanjing Med Univ, Nanjing Brain Hosp, Nanjing, Peoples R China
[4] Nanjing Med Univ Sch Publ Hlth, Nanjing, Peoples R China
关键词
Migraine; Incidence; Women; Childbearing age; Chinese; EPIDEMIOLOGY; SEX;
D O I
10.1186/s10194-023-01692-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundMigraine is a primary headache, which has been producing heavy disease burden globally. There is no data on the incidence of migraine among women of childbearing age worldwide, including China. This study aimed to investigate the time trend in incidence rate of migraine among women of childbearing age in China from 1999 to 2019, and to make a prediction for 2030.MethodsData on migraine incidence and population among women of childbearing age in China were derived from the Global Burden of Diseases Study 2019. Crude and age-standardized incidence rates of migraine (CIR, ASIR) were presented. The trend in migraine during 1990-2019 was examined using annual percent change and average annual percent change based on Joinpoint regression models. Age-period-cohort model was introduced to estimate the independent effect of age, period and cohort on migraine incidence rate among participants over the three decades. Bayesian age-period-cohort analysis was conducted to predict migraine incidence rate for 2030 among women of childbearing age in China.ResultsFor women of childbearing age in China, the case number, CIR and ASIR of migraine kept rising, with a cumulative percentage increase of 10.87%, 2.01% and 5.65%, respectively, from 1990 to 2019. An annual percent increase of 0.18% in the ASIR was observed over the three decades. As for the age, period and cohort effects, the adjusted cohort-specific relative risks constantly increased from 0.91 (95% CI: 0.90, 0.93) in the 1940-1949 cohort to 1.04 (95% CI: 1.03, 1.05) in the 1995-2004 cohort, while the period-specific relative risks initially declined from 1.00 (95% CI: 0.99, 1.00) in 1990-1994 cohort to 0.99 (95% CI: 0.98, 0.99) in 1995-1999 cohort, and then increased to 1.04 (95% CI: 1.03, 1.04) in 2015-2019 cohort. Moreover, the age-specific relative risks of migraine followed a bimodal pattern with peaks at the age-group of 25-29 years (CIR = 1718.27/100000) and 35-39 years (CIR = 1635.18/100000). Projection modeling showed that the CIR and ASIR of migraine will continue to significantly increase from 2020 to 2030.ConclusionMigraine incidence remained an increasing trend from 1990 to 2019 and is projected to continually increase till 2030 among women of childbearing age in China. This study has important public health implication for population-level migraine prevention in China. Precision intervention strategies and approaches shall be considered in campaigns initiated for migraine prevention among Chinese women of childbearing age.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The Iodine Status and Prevalence of Thyroid Disorders Among Women of Childbearing Age in China: National Cross-sectional Study
    Li, Yongze
    Shan, Zhongyan
    Teng, Weiping
    ENDOCRINE PRACTICE, 2021, 27 (10) : 1028 - 1033
  • [32] Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035
    Li, Yizhen
    Zheng, Jinxin
    Deng, Yujiao
    Deng, Xinyue
    Lou, Weiyang
    Wei, Bajin
    Xiang, Dong
    Hu, Jingjing
    Zheng, Yi
    Xu, Peng
    Yao, Jia
    Zhai, Zhen
    Zhou, Linghui
    Yang, Si
    Wu, Ying
    Kang, Huafeng
    Dai, Zhijun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study
    Singh, Mayank
    Jha, Ravi Prakash
    Shri, Neha
    Bhattacharyya, Krittika
    Patel, Priyanka
    Dhamnetiya, Deepak
    BMC CANCER, 2022, 22 (01)
  • [34] Time trends in type 2 diabetes mellitus incidence across the BRICS from 1990 to 2019: an age-period-cohort analysis
    Sun, Panglin
    Wen, Haoyu
    Liu, Xiaoxue
    Ma, Yudiyang
    Jang, Jie
    Yu, Chuanhua
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [35] Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years
    Feng, Jianyang
    Xu, Lijiang
    Chen, Yangping
    Lin, Rongjin
    Li, Haoxian
    He, Hong
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [36] Global Trends in Incidence and Burden of Urolithiasis from 1990 to 2019: An Analysis of Global Burden of Disease Study Data
    Lang, Jacob
    Narendrula, Aparna
    El-Zawahry, Ahmed
    Sindhwani, Puneet
    Ekwenna, Obi
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 35 : 37 - 46
  • [37] Secular Trends in the Incidence of and Mortality Due to Alzheimer's Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis
    Gao, Yongliang
    Liu, Xiaonan
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [38] Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis
    Liu, Xiaoxue
    Yu, Chuanhua
    Wang, Yongbo
    Bi, Yongyi
    Liu, Yu
    Zhang, Zhi-Jiang
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (01)
  • [39] Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034
    Li, Shuang
    Huang, Min
    Zhu, Yan
    Zeng, Hai
    Zhang, Fan
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2024, 33 (03) : 252 - 261
  • [40] The Global Trends and Regional Differences in Incidence of Dengue Infection from 1990 to 2019: An Analysis from the Global Burden of Disease Study 2019
    Du, Min
    Jing, Wenzhan
    Liu, Min
    Liu, Jue
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1625 - 1643